The Role of EMMPRIN in Perirenal Fat Invasion Clear Cell Renal Cell Carcinoma
Keywords:Clear cell renal cell carcinoma, EMMPRIN, perirenal fat invasion
Renal Cell Carcinoma (RCC) is a common malignancy of the kidney, and Clear Cell Renal Cell Carcinoma
(CCRCC) is the most common type. Accurate prediction of prognosis is valuable for therapy and follow
up. EMMPRIN is a transmembrane protein of the immunoglobulin family and is associated with tumour
proliferation, invasion and metastasis. This study aims to prove the role of EMMPRIN in perirenal fat
invasion CCRCC. This analytic observational study with a cross-sectional approach conducted in Anatomical
Pathology Institute of Dr. Soetomo Hospital, Surabaya that used 44 samples of paraffin blocks from radical
nephrectomy preparations for CCRCC patients at the period of January 2013-December 2018, which were
divided based on perirenal fat invasion status. The analyzed was using Spearman test. EMMPRIN expression
is positively correlated with perirenal fat invasiveness (p = 0.019) in clear cell renal cell carcinoma.
EMMPRIN expression is related with perirenal fat invasiveness, in clear cell renal cell carcinoma.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions